Becher R - Search Results

1

Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b.

Niederle N, Kloke O, May D, Becher R, Osieka R, Schmidt CG. Niederle N, et al. Among authors: becher r. Invest New Drugs. 1987;5 Suppl:S19-25. doi: 10.1007/BF00207259. Invest New Drugs. 1987. PMID: 3474219

2

[alpha 2-interferon: preliminary treatment results in chronic myeloid leukemia].

Niederle N, Kloke O, Doberauer C, Becher R, Beelen DW, Schmidt CG. Niederle N, et al. Among authors: becher r. Dtsch Med Wochenschr. 1986 May 16;111(20):767-72. doi: 10.1055/s-2008-1068529. Dtsch Med Wochenschr. 1986. PMID: 3516621 Clinical Trial. German.

3

Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patients.

Niederle N, Moritz T, Kloke O, Wandl U, May D, Becher R, Franz T, Opalka B, Schmidt CG. Niederle N, et al. Among authors: becher r. Eur J Cancer. 1991;27 Suppl 4:S7-14. doi: 10.1016/0277-5379(91)90556-s. Eur J Cancer. 1991. PMID: 1799485

4

Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma.

Opalka B, Wandl UB, Becher R, Kloke O, Nagel-Hiemke M, Moritz T, Beer U, Seeber S, Niederle N. Opalka B, et al. Among authors: becher r. Blood. 1991 Nov 1;78(9):2188-93. Blood. 1991. PMID: 1932740 Free article. Clinical Trial.

5

Treatment of chronic myelogenous leukemia with interferons alpha and gamma.

Kloke O, May D, Wandl U, Becher R, Opalka B, Beer U, Niederle N. Kloke O, et al. Among authors: becher r. Blut. 1990 Jul;61(1):45-6. doi: 10.1007/BF01739433. Blut. 1990. PMID: 2117476

6

Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia.

Kloke O, Becher R, Niederle N. Kloke O, et al. Among authors: becher r. Blut. 1987 Nov;55(5):453-8. doi: 10.1007/BF00367463. Blut. 1987. PMID: 3118992

7

Long-term treatment of chronic myelogenous leukemia with different interferons: results from three studies.

Niederle N, Kloke O, Wandl UB, Becher R, Moritz T, Opalka B. Niederle N, et al. Among authors: becher r. Leuk Lymphoma. 1993 Jan;9(1-2):111-9. doi: 10.3109/10428199309148513. Leuk Lymphoma. 1993. PMID: 8477190 Clinical Trial.

8

Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia.

Kloke O, Niederle N, Qiu JY, Wandl U, Moritz T, Nagel-Hiemke M, Hawig I, Opalka B, Seeber S, Becher R. Kloke O, et al. Among authors: becher r. Br J Haematol. 1993 Mar;83(3):399-403. doi: 10.1111/j.1365-2141.1993.tb04663.x. Br J Haematol. 1993. PMID: 8485045

9

Prognostic impact of interferon alpha-induced cytogenetic remission in chronic myelogenous leukaemia: long-term follow-up.

Kloke O, Niederle N, Opalka B, Hawig I, Seeber S, Becher R. Kloke O, et al. Among authors: becher r. Eur J Haematol. 1996 Jan-Feb;56(1-2):78-81. doi: 10.1111/j.1600-0609.1996.tb00299.x. Eur J Haematol. 1996. PMID: 8599999 Clinical Trial.

10

Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia.

Wandl UB, Kloke O, Nagel-Hiemke M, Moritz T, Becher R, Opalka B, Holtkamp W, Bartels H, Seeber S, Niederle N. Wandl UB, et al. Among authors: becher r. Br J Haematol. 1992 Aug;81(4):516-9. doi: 10.1111/j.1365-2141.1992.tb02984.x. Br J Haematol. 1992. PMID: 1390238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters